IcsA Is a Shigella flexneri Adhesin Regulated by the Type III Secretion System and Required for Pathogenesis  by Brotcke Zumsteg, Anna et al.
Cell Host & Microbe
ArticleIcsA Is a Shigella flexneri Adhesin
Regulated by the Type III Secretion System
and Required for Pathogenesis
Anna Brotcke Zumsteg,1 Christian Goosmann,2 Volker Brinkmann,2 Renato Morona,3 and Arturo Zychlinsky1,*
1Department of Cellular Microbiology
2Microscopy Core Facility
Max Planck Institute for Infection Biology, Berlin 13353, Germany
3School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5000, South Australia, Australia
*Correspondence: zychlinsky@mpiib-berlin.mpg.de
http://dx.doi.org/10.1016/j.chom.2014.03.001SUMMARY
Following contact with the epithelium, the enteric
intracellular bacterial pathogen Shigella flexneri in-
vades epithelial cells and escapes intracellular phag-
osomal destruction using its type III secretion system
(T3SS). The bacterium replicates within the host cell
cytosol and spreads between cells using actin-
based motility, which is mediated by the virulence
factor IcsA (VirG). Whereas S. flexneri invasion is
well characterized, adhesion mechanisms of the
bacterium remain elusive. We found that IcsA also
functions as an adhesin that is both necessary and
sufficient to promote contact with host cells. As
adhesion can be beneficial or deleterious depending
on the host cell type, S. flexneri regulates IcsA-
dependent adhesion. Activation of the T3SS in
response to the bile salt deoxycholate triggers
IcsA-dependent adhesion and enhances pathogen
invasion. IcsA-dependent adhesion contributes to
virulence in amousemodel of shigellosis, underscor-
ing the importance of this adhesin to S. flexneri path-
ogenesis.
INTRODUCTION
Shigella species are the etiological agent of bacillary dysentery.
This diarrheal disease is a significant public health problem, with
an estimated incidence of roughly 160 million people per year
(Bardhan et al., 2010; Kotloff et al., 1999). Shigellae are trans-
mitted via the fecal oral route, and infections are initiated by
invasion of M cells in the colon (Perdomo et al., 1994). The bac-
terium is then taken up by underlying macrophages, where it
induces a rapid proinflammatory cell death by activating the in-
flammasome (Hilbi et al., 1997; Zychlinsky et al., 1994). The bac-
terium invades the basal-lateral side of the epithelium, escapes
the phagocytic vacuole, and replicates within the cytosol.
Shigella can spread intercellularly using actin-based motility
(ABM), a process by which the bacterium recruits the host cell
cytoskeleton to create an actin comet tail. The comet tail propelsCellthe bacterium through the cytosol and into adjacent cells. This
phenomenon has been studied in vitro using confluent mono-
layers, where infection of an epithelial cell with one bacterium
can result in formation of a plaque. The virulence factors required
for this intracellular lifestyle are encoded on a large virulence
plasmid, which is conserved among Shigellae (Marteyn et al.,
2012; Sansonetti et al., 1982).
The type III secretion system (T3SS) is required for host cell
invasion and vacuolar escape. The T3SS is a multimolecular
complex, composed of a basal body, needle, and tip, which
resembles a syringe upon assembly (Marteyn et al., 2012). The
basal body spans both the inner and outer membranes and is
connected to the needle that extends out from the bacterium.
The needle is capped by IpaD, which binds to translocon pro-
teins IpaB and IpaC that connect the needle to the host cell.
The T3SS model proposes that the syringe structure creates a
conduit that allows effector proteins to be delivered from the
cytoplasm of the bacterium directly into the target host cell.
A diverse set of effector proteins then manipulate various as-
pects of host cell biology and immunology. Effector secretion
is temporally regulated, as expression of the second set of effec-
tors is dependent on secretion of the first set (Mavris et al., 2002;
Parsot et al., 2005). This is accomplished using chaperones
as feedback sensors of T3SS activation; chaperones of early-
secreted effectors are left unoccupied upon induction of the
T3SS, allowing reassembly into transcriptional regulatory com-
plexes. Upon secretion of IpaB, IpaC, and OspD1, IpgC and
MxiE are freed and associate with each other to positively regu-
late expression of roughly 18 effectors (Kane et al., 2002; Le Gall
et al., 2005; Mavris et al., 2002; Parsot et al., 2005). Residing at
the tip of the needle, IpaB and IpaD play an important additional
role in regulating the T3SS by preventing premature release of
effectors (Me´nard et al., 1994).
ABM is mediated by the autotransporter protein IcsA (VirG)
(Bernardini et al., 1989; Goldberg and Theriot, 1995; Kocks
et al., 1995;Makino et al., 1986). As an autotransporter, secretion
of IcsA is independent of the T3SS. IcsA localization in the
outer membrane is asymmetric, and newly formed IcsA is pre-
ferentially incorporated into the old pole of the bacterium
(Goldberg et al., 1993a, 1994). This polar localization is impor-
tant for driving unidirectional movement of the bacterium
(Goldberg and Theriot, 1995). The protease IcsP (SopA) helps
to maintain polarity by cleaving IcsA that extends beyond theHost & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Inc. 435
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Figure 1. DipaB and DipaD Mutants Hyperadhere to Host Cells, and This Requires Secretion-Competent Needles
(A) HeLa cells infected for 15 min with the indicated strains. Bacteria are in red, actin in green, and nuclei in blue. Images were taken using a 633 objective.
(B and C) Adhesion rate of S. flexneri mutants during HeLa (B) or BMDM (C) infections. Data are the mean ± SEM of at least three independent experiments.
(D) Adhesion rate of S. flexneri mutants to human PMNs. Adhesion rate was quantified by microscopy from PMNs infected with the indicated strains. Data
are expressed as the mean ± SEM of the bacteria/PMN for each field, and over 1,000 PMNs were quantified per strain. Shown is one representative of two
independent experiments.
(E) Secreted proteins from overnight culture supernatants from the indicated strains. Significance was calculated using a t test, and p values are as follows:
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. See also Figure S1 and Tables S1, S2, and S3.
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S. flexneri IcsA Is an Adhesinpole (Fukuda et al., 1995; Shere et al., 1997; Steinhauer et al.,
1999; Tran et al., 2013). In the host cytosol, IcsA interacts directly
with N-WASP, which in turn recruits Arp2/3, resulting in indirect
polymerization of host cell actin by the bacterium (Egile et al.,
1999; Suzuki et al., 1998).
The ability to adhere to host cells is crucial for intracellular
pathogens, and adhesins are a diverse class of virulence factors
(Kline et al., 2009). Notably, few studies have examined molecu-
lar mechanisms of Shigella adhesion, and no adhesin has been
identified (Faherty et al., 2012; Pope et al., 1995). Interestingly,
both DipaB and DipaD mutants are hyperadhesive, although
the mechanism is not clear. Using these mutants as a tool to
study adhesion processes, we found that DipaB and DipaD
mutants hyperadhere to a variety of host cells, surprisingly using
one pole. IcsA was necessary for hyperadhesion of these
S. flexneri mutants and sufficient to promote adhesion of
E. coli, demonstrating that IcsA plays two roles in S. flexneri
infections. While IcsA is expressed by both the wild-type and
the hyperadhesive DipaD mutant, we observed differences in
protease accessibility to IcsA between the strains, suggesting
that adhesive IcsA may adopt an alternate conformation. Treat-
ment with the bile salt deoxycholate induced IcsA-dependent436 Cell Host & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Inadhesion in a T3SS-dependent manner, showing that IcsA
becomes adhesive in response to physiological stimuli. We
identified an icsA insertion mutant that was deficient for adhe-
sion, but not ABM, allowing us to separate these two functions.
This mutant was attenuated in a mouse model of shigellosis,
demonstrating that IcsA-dependent adhesion is necessary for
S. flexneri infections.
RESULTS
DipaB and DipaD Mutants Hyperadhere to Host Cells,
and This Requires a Secretion-Competent T3SS Needle
We used DipaB and DipaD mutants, which are known to be hy-
peradhesive (Me´nard et al., 1993), as a tool to identify adhesins
in S. flexneri. Wild-type, virulence plasmid-cured S. flexneri
(BS176), and DipaC strains adhered to epithelial cells and mac-
rophages poorly (1%). In contrast, DipaB and DipaD mutants
hyperadhered to epithelial cells (Figures 1A, 1B, and S1E avail-
able online), bone marrow-derived macrophages (BMDM)
(Figure 1C), and human neutrophils (PMN) (Figure 1D). We
validated our plate-based assay by quantifying adhesion to
HeLa cells via microscopy and found similar results (Figure S1A).c.
Figure 2. DipaB and DipaD Mutants Hyperadhere Using Their Poles
Scanning electron micrographs of human PMNs or BMDMs infected with an moi of 20 bacteria per BMDM or 100 bacteria per PMN at 3 min postinfection.
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S. flexneri IcsA Is an AdhesinSince the DipaD mutant exhibited an adhesion phenotype
more robust than that of theDipaBmutant, we focused on hyper-
adhesion in this background and found that complementation
with wild-type ipaD restored theDipaDmutant to wild-type levels
of adhesion (Figures 1B and 1C).
IpaD sits at the tip of the T3SS needle and recruits IpaB to
mediate contact with host cells. DipaB and DipaD mutants are
no longer invasive, since the translocon is absent; however,
they still synthesize the T3SS. We found that secretion-compe-
tent T3SS needles are required for hyperadhesion, as a needle-
less DipaDmutant (DipaDDspa33) was no longer hyperadhesive
(Figures 1B and 1C) (Morita-Ishihara et al., 2006). However, a
DipaD mutant that produced extra-long needles due to deletion
of a needle-length regulator (DipaDDspa32) (Tamano et al., 2002)
hyperadhered to host cells (Figure S1B–S1D), demonstrating
that while the T3SS is necessary for hyperadhesion, needle
length is not important.
In addition to promoting contact with host cells, IpaB and
IpaD prevent deregulated secretion of T3SS effectors. Conse-
quently, DipaB and DipaD mutants hypersecrete effectors
compared to the wild-type (Me´nard et al., 1994). To exclude
the possibility that an effector could contribute to hyper-
adhesion, we constructed a DipaBCDADmxiE mutant. This
mutant has a deregulated T3SS, since IpaB and IpaD are
absent, but lacks expression of almost all effectors either
through direct deletion or because the transcriptional activator
MxiE is absent. Consequently, compared to a DipaD mutant,
the DipaBCDADmxiE mutant secreted very few effectors
(Figure 1E). The DipaBCDADmxiE mutant hyperadhered to host
cells, suggesting that T3SS effectors were not responsible for
the hyperadhesion phenotype (Figures 1B and 1C). Additionally,
early-secreted effectors involved in invasion (IpgB1, IpgB2,
and IpgD) and the chaperone Spa15 were not necessary for
hyperadhesion of the DipaD mutant (Figures S1C and S1D and
Table S3). Together, these data are consistent with a modelCellwhere hyperadhesion is regulated by the activity of the T3SS,
rather than secretion of a specific effector.
DipaB and DipaD Mutants Adhere Using Their Poles
We further characterized interactions between DipaB and DipaD
mutants with host cells using scanning electron microscopy
(SEM). Interestingly, hyperadhesive mutants predominantly
contacted macrophages and neutrophils using one pole (76/
114 bacteria) (Figure 2). In contrast, the wild-type contacted
host cells using the long axis (22/23 bacteria). These data sug-
gested that a molecule with a polar localization was promoting
hyperadhesion to host cells in DipaB and DipaD mutants. As
the T3SS apparatus is not localized in a polar manner, the mole-
cule promoting adhesion was likely not the needle itself (Blocker
et al., 1999; Demers et al., 2013; Marteyn et al., 2010; Olive et al.,
2007; West et al., 2005) .
IcsA Is Necessary for Hyperadhesion of S. flexneri
Mutants and Sufficient to Promote Adhesion of E. coli
Since IcsA localizes to one pole (Goldberg et al., 1993b), we
tested whether IcsA contributes to hyperadhesion. Indeed, de-
leting icsA abrogated hyperadhesion of the DipaD mutant to
HeLa cells and macrophages (Figures 3A and 3B). Hyperadhe-
sion of the DipaDDicsA strain could be complemented in trans
with either wild-type levels of IcsA (Figure 3B) or overexpression
of IcsA from an inducible promoter (Figure 3A). Furthermore,
deleting icsA abolished polar adhesion to host cells, as the
DipaDDicsA mutant adhered to macrophages using its long
axis (Figure 3E), demonstrating that icsA is required for the polar
hyperadhesion phenotype of the DipaD mutant. Since the T3SS
was required for hyperadhesion of the DipaDmutant (Figure 1A),
we tested whether deletion of icsA altered T3SS activity. Hyper-
secretion of effectors was identical in the DipaD and DipaDDicsA
strains (Figure 3C), confirming that IcsA is not required for T3SS
activation. In contrast to the DipaD mutant, neither deleting norHost & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Inc. 437
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Figure 3. IcsA Is Necessary for Hyperadhesion of S. flexneri Mutants and Sufficient to Promote Adhesion of E. coli
(A and B) Adhesion rate of S. flexneri mutants at 15 min during HeLa (A) or BMDM (B) infections.
(C) Secreted proteins from overnight culture supernatants from the indicated strains.
(D) Adhesion rate of BS176 and E. coli BL21 expressing IcsA or harboring a vector control during HeLa infections. Data are the mean ± SEM of at least three
independent experiments. Significance was calculated using a t test; ***p < 0.001.
(E) Scanning electron micrographs of BMDMs infected with indicated mutants at an moi of 20 bacteria per BMDM at 3 min postinfection. See also Tables S1, S2,
and S3.
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S. flexneri IcsA Is an Adhesinoverexpressing icsA altered the adhesion rate of wild-type
S. flexneri (Figures 3A and 3B). Furthermore, overexpression of
icsA was not sufficient to induce adhesion of Shigella lacking
the virulence plasmid (BS176; Figure 3D), suggesting that an
activation step is required for IcsA-dependent adhesion in
Shigella strains.
Our data indicated that IcsA is an adhesin in S. flexneri that
requires the T3SS for activity. To test whether IcsA is sufficient
to promote adhesion to host cells in the absence of the T3SS,
we expressed IcsA heterologously in E. coli (BL21). E. coli ex-
pressing IcsA adhered to epithelial cells at a rate significantly
higher than that of E. coli harboring a vector control (Figure 3D),
showing that IcsA is an adhesin and that IcsA does not require
the T3SS or effectors for adhesion to host cells in E. coli.
IcsA Has Altered Protease Accessibility in the DipaD
Mutant
Expression of IcsA is induced during growth at 37C (Parsot,
2005). This implies that both the wild-type and the DipaDmutant
are capable of expressing IcsA during our growth conditions,
making it unclear why IcsA-dependent adhesion was only
observed in the DipaD background. Therefore, we examined a438 Cell Host & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Invariety of criteria that could influence IcsA activity. IcsA was
detected at the pole of wild-type, DipaD, and Dspa33 mutants
(Figure 4A,R95%of IcsA-positive bacteria), ruling out any differ-
ences in IcsA localization between the strains. Furthermore, sur-
face IcsA levels were indistinguishable between hyperadhesive
DipaD and DipaB mutants and low-adhesive Dspa33, DipaC,
and wild-type strains (Figure 4B), suggesting that the hyper-
adhesion of the DipaD mutant is not due to increased quantity
of IcsA. We also explored whether lipopolysaccharide (LPS)
length might regulate the accessibility of IcsA, since several
studies have demonstrated that alterations to LPS composition
impacts actin-based motility (Hong and Payne, 1997; Morona
and Van Den Bosch, 2003; Okada et al., 1991; Sandlin et al.,
1995; Van den Bosch et al., 1997). We compared the purified
LPS of adhesive (DipaD and DipaB) and nonadhesive strains
(WT and Dspa33) and found that there were no differences
between the O-antigen profiles (Figure S2).
Another possible explanation for our data is that IcsA has
alternate conformations. To test this, we digested IcsA from
the DipaD and wild-type strains by limited proteolysis with
neutrophil elastase (NE). NE is a protease expressed by neutro-
phils and has previously been shown to efficiently cleave IcsAc.
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Figure 4. IcsA Has Altered Protease Accessibility in Hyperadhesive Strains
(A) Merge of fluorescence microscopy (green) and DIC (gray). S. flexneri strains were fixed, and the localization of IcsA was determined by immunofluorescence
using an antibody against IcsA. Images were acquired using a 1003 objective.
(B) Quantification of surface IcsA levels by flow cytometry. Data are from single bacteria, as any aggregated bacteria were gated and removed from analysis.
(C) Limited proteolysis assay usingDspa33DicsA, DicsA, and DipaDDicsAmutants or BS176 and E. coli BL21 expressing IcsA-HA pUC19. Aliquots were taken at
0, 1, 10, 30, and 60min postcleavagewith 25 nMNE or 2 mg/ml proteinase K (PK) at 30min, and IcsA degradation was assessed bywestern blot using an antibody
against HA. NE-resistant fragments are indicated by an asterisk (*). See also Figures S2 and S3.
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S. flexneri IcsA Is an Adhesin(Averhoff et al., 2008; Weinrauch et al., 2002). To perform these
experiments, we used Dspa33DicsA, DicsA, and DipaDDicsA
mutants complemented with a hemagglutinin (HA)-tagged
IcsA. The IcsA-HA construct complemented hyperadhesion in
the DipaDDicsA mutant and did not alter the adhesion rate of
the DicsA or Dspa33DicsA mutants, showing that the tagged
protein is fully functional (Figure S3). Prior to protease cleavage,
there were no differences in the molecular weight of IcsA-HA in
adhesive and nonadhesive strains (Figure 4C), suggesting that
there are no large modifications to the protein that regulate
adhesion. However, digestion of IcsA-HA by NE was altered in
the DipaDDicsA mutant as compared to the Dspa33DicsA
and DicsA strains. While the full-length protein was efficiently
cleaved, the DipaD mutant had IcsA fragments that were more
resistant to degradation by NE.
To substantiate these findings, we compared the adhesion
and limited proteolysis of E. coli BL21 and Shigella BS176
(VP) expressing IcsA-HA pUC19. We found that IcsA-HA was
sufficient to promote adhesion of E. coli but not BS176
(Figure S3B). Furthermore, we found that digestion of IcsA-HA
was altered in E. coli versus BS176 (Figure 4C). As seen withCellthe DipaDDicsA mutant, IcsA-HA expressed by E. coli had
protease-resistant fragments as compared to IcsA-HA ex-
pressed in BS176. Additionally, full-length IcsA-HA was more
resistant to NE degradation when expressed in E. coli as
compared to any of the Shigella strains. To determine whether
a significant portion of IcsA-HA was intracellular, and therefore
inaccessible to NE, we treated BS176 and E. coliwith proteinase
K. Full-length IcsA-HA was cleaved by proteinase K, suggesting
that the protein was extracellular and accessible to protease
cleavage by NE. Taken together, these results suggest that
IcsA has altered physicochemical properties in hyperadhesive
strains.
Deoxycholate Treatment Activates IcsA-Dependent
Adhesion
Our experiments suggested a link between IcsA adhesiveness
and activation of the T3SS. Therefore, we hypothesized that an
environmental cue that activates the T3SS would trigger IcsA-
dependent adhesion in wild-type S. flexneri. Previous studies
showed that physiological concentrations of the bile salt deoxy-
cholate (DOC) causes increased adhesion and invasion ofHost & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Inc. 439
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Figure 5. Deoxycholate Treatment Activates IcsA-Dependent Adhesion
(A and B) Adhesion rate of S. flexneri mutants at 15 min during HeLa (A) or BMDM (B) infections.
(C) Invasion assay at 1.5 hr postinfection. Adhesion and invasion rates were normalized to the wild-type untreated sample. Data are the mean ± SEM of at least
three independent experiments. Significance was calculated using a t test, and p values are as follow: *p < 0.05, **p < 0.01.
(D) Limited proteolysis assay usingDspa33DicsA andDicsA complemented with IcsA-HA pUC19 grown in the presence of 2.5mMDOC. Aliquots were taken at 0,
1, 10, 30, and 60min postcleavage with 34 nMNE, and IcsA degradation was assessed by western blot using an antibody against HA. NE-resistant fragments are
indicated by an asterisk (*). See also Figure S4.
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S. flexneri IcsA Is an AdhesinShigella species (Pope et al., 1995) that are dependent on the
T3SS (Barta et al., 2012), prompting us to test whether IcsA-
dependent adhesion might be activated by DOC. Indeed, treat-
ment with 2.5 mM DOC increased the adhesion and invasion
rates of wild-type S. flexneri (Figures 5A–5C). The increase in
adhesion upon DOC treatment was partially dependent on
icsA, as DOC-treated DicsA mutants were significantly less ad-
hesive than the DOC-treated wild-type both in a plate-based
assay and when adhesion was quantified by microscopy (Fig-
ures 5A, 5B, and S4). Increased invasion due to DOC treatment
was almost entirely dependent on icsA, as the invasion rate of
the DicsA mutant was significantly lower than that of the DOC-
treated wild-type (Figure 5C). To determine whether functional
needles were involved in the DOC response observed here, we
tested the effect of DOC treatment on needleless S. flexneri
(Dspa33) mutants. DOC treatment did not alter the low adhesion
rate of Dspa33 mutant, showing that needles were required to
activate both IcsA-dependent and -independent adhesion in
wild-type S. flexneri. A previous study demonstrated that
OspE1/OspE2 are required for DOC-induced Shigella adhesion
to polarized epithelial monolayers (Faherty et al., 2012). In
contrast to that study, we found that neither OspE1/OspE2 nor
its transcriptional regulator MxiE were required for DOC-induced
adhesion in our system (Figure S4C). Taken together, these
data suggest that DOC treatment activates IcsA-dependent
adhesion in a T3SS-regulated manner, resulting in enhanced
invasion of S. flexneri.440 Cell Host & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier InDOC treatment also altered NE proteolysis of IcsA. As
observed with the DipaDDicsA mutant, the DOC-treated DicsA
had an IcsA-HA fragment around 40 kDa that was more resistant
to degradation by NE compared to the Dspa33DicsA mutant
grown in DOC (Figure 5D). While this fragment was less pro-
nounced than in experiments using DipaDDicsA or E. coli ex-
pressing IcsA-HA, it was consistently observed (Figure S4D).
These data suggest that DOC treatment indirectly alters IcsA
properties, resulting in adhesive IcsA.
ABM and Adhesion Can Be Phenotypically Separated
The data presented above suggest that IcsA plays two roles
during shigellosis by promoting both adhesion to host cells
and ABM. We asked whether distinct regions of IcsA were
necessary for each of these functions. We tested a previously
characterized IcsA insertion library (May and Morona, 2008)
to identify IcsA mutants with distinct phenotypes. The library
was screened for the ability to complement adhesion in the
DipaDDicsA background and invasion following DOC treatment
in the DicsA background. Invasion was chosen as opposed to
adhesion in the DOC-treatedDicsAmutant, since this phenotype
showed greater differences between the wild-type and DicsA
mutant (Figures 5A and 5C). The majority of the IcsA insertion
mutations that were previously found to reduce plaque formation
also inhibited DOC-induced invasion (data not shown), suggest-
ing that there is a high degree of overlap between functional
domains for ABM and adhesion. However, we identified twoc.
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Figure 6. IcsA-Dependent Adhesion Is Required for Pathogenesis
(A) Invasion rate of the DicsA mutant at 90 min.
(B andC) Adhesion rate ofS. flexneriDipaDDicsAmutant (B) or BS176 and E. coliBL21 (C) at 15min. Strains were complementedwith the indicated plasmids, and
HeLa cells were infected for (A)–(C). Adhesion and invasion rates were normalized to the pIcsA-expressing sample in (A) and (B). Data are the mean ± SEM of at
least three independent experiments. Significance was calculated using a t test.
(D) Sereny test. Mice were infected with 33 107–43 107 cfu in 2 ml. Eyes were blindly scored on a scale of 0 (no inflammation), 1 (mildly inflamed), or 2 (inflamed),
and each dot represents the score from one mouse. The data shown are from two independent experiments at 48 hr postinfection. Significance was calculated
using a Mann-Whitney test. p values are as follows: *p < 0.05, **p < 0.01, and ***p < 0.001.
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S. flexneri IcsA Is an Adhesinplaque-independent insertion mutants (i148 and i386) that ex-
hibited mildy reduced IcsA-dependent adhesion; therefore, we
combined the two mutations. The combined mutant, hereafter
referred to as IcsAadhesion, was significantly reduced for adhe-
sion in the DipaDDicsA mutant and invasion following DOC
treatment in the DicsA mutant (Figures 6A and 6B). Importantly,
the DicsA + pIcsAadhesion mutant formed wild-type plaques on
HeLa monolayers, showing that ABM was not impaired in this
mutant, consistent with the previous results for the individual
insertion strains (May and Morona, 2008). The IcsAadhesion
mutant was also unable to promote adherence of E. coli BL21
compared to a vector control (Figure 6C), whereas wild-type
IcsA significantly increased adhesion in this background. These
data show that IcsA has distinct regions that contribute to adhe-
sion, allowing us to phenotypically separate adhesion and ABM.
IcsA-Dependent Adhesion Is Required for Pathogenesis
DicsA mutants are attenuated in human volunteers, a macaque
model of dysentery, and a mouse model of shigellosis where
the bacterium is inoculated into the eye (Sereny test) (Bernardini
et al., 1989; Kotloff et al., 2002; Makino et al., 1986; Sansonetti
et al., 1991), but in light of our data, it is unclear which of the
two functions contributes to pathogenesis. We used the Sereny
test to compare the keratoconjunctivitis induced by DicsA
mutants complemented with wild-type pIcsA, empty vector
(pBR322), and pIcsAadhesion. Infection with the DicsA + pIcsACellstrain resulted in conjunctivitis that peaked at 2 days post-
infection, while the DicsA + pBR322 strain did not elicit
an inflammatory response (Figure 6D). Notably, the DicsA +
pIcsAadhesion mutant induced conjunctivitis that was signifi-
cantly milder than the infection caused by S. flexneri expressing
wild-type IcsA. These data show that IcsA-dependent adhesion
contributes to pathogenesis, underscoring the importance of
this adhesin to shigellosis.
DISCUSSION
Our data indicate that IcsA plays two roles in Shigella pathogen-
esis, as an adhesin and as the mediator of ABM. We propose a
model whereShigella encounters bile salts in the intestine, which
trigger a change in IcsA that makes it adhesive. This primes
Shigella to adhere to the epithelium, facilitating T3SS-dependent
invasion. After escaping the vacuole, Shigella replicates in the
cytosol and IcsA plays a different and essential role by directing
intercellular spread using ABM. By regulating IcsA-dependent
adhesion, the bacterium can integrate environmental cues to
target cell types at particular periods during the infection. This
has important implications for host cell invasion, inflammatory
regulation, and transmission.
We found that IcsA was necessary for hyperadhesion of
S. flexneri mutants, as well as sufficient to induce adhesion of
E. coli, categorizing IcsA as a bona fide adhesin. In contrast,Host & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Inc. 441
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S. flexneri IcsA Is an AdhesinIcsA-dependent adhesion was not utilized by wild-type
S. flexneri grown in standard broth cultures at 37C. Many path-
ogens require physiological cues for optimal virulence, for
example low calcium conditions in the case of Yersinia species
(Straley et al., 1993) and high osmolarity and low oxygen condi-
tions for Salmonella enterica (Bajaj et al., 1996). We found that
IcsA-dependent adhesion was induced by growth in the bile
salt DOC, leading to roughly ten times more invasion of the
bacterium than the untreated wild-type. Since DOC is a relevant
physiological cue encountered by Shigella, we propose that
DOC-treated S. flexneri better represents the infectious bacte-
rium. By uncovering IcsA-dependent adhesion, we contribute
to understanding howDOC increases infectivity at a mechanistic
level.
IcsA is expressed by both adhesive and nonadhesive Shigella
strains, but it is not clear how IcsA-dependent adhesion is regu-
lated on a molecular level. Notably, we found that accessibility
of IcsA to NE was altered in the adhesive state compared to
the nonadhesive state, suggesting that there are physicochem-
ical alterations to IcsA that explain the observed differences
in adhesion. One explanation is that IcsA folds differently when
functioning as an adhesin. It is also possible that IcsA is post-
translationally modified in a way that alters protease cleavage
or is masked by interactions with other molecules. Integrating
our data, we predict that the factor governing IcsA adhesion
in S. flexneri, whether a chaperone, a modifying enzyme, or a
cofactor, is regulated by the activity of the T3SS. Since IcsA is
sufficient to promote adhesion of E. coli, but not virulence
plasmid-cured Shigella (BS176), our data would be consistent
with either (1) a factor that inhibits IcsA-dependent adhesion in
BS176 that is inhibited and/or downregulated by the activity of
the T3SS in wild-type Shigella or (2) a factor that promotes
IcsA-dependent adhesion expressed by both E. coli and Shigella
that is upregulated and/or activated by the activity of the T3SS.
The distinction between these two possibilities awaits further
research, including screening for a putative inhibitory factor.
There are three experiments that support the link between
IcsA-dependent adhesion and the activity of the T3SS in
S. flexneri. First, the DipaD mutant, which has a constitutively
active T3SS, requires icsA for hyperadhesion. Second, deleting
needles in the DipaD background eliminates IcsA-dependent
hyperadhesion. Third, the bile salt DOC induces IcsA-dependent
adhesion and invasion in wild-type S. flexneri, whereas a needle-
less Shigella mutant does not respond to DOC. This mutant still
expresses IcsA, ruling out a direct effect of DOC on IcsA itself.
It is unclear how the signal transduction events occur, since
activation of IcsA-dependent adhesion does not require MxiE
or IpgC (data not shown). It is possible that another chaperone
serves as a feedback sensor of T3SS activation or that signal
transduction occurs through a novel mechanism. Regardless,
our data place IcsA-dependent adhesion downstream of the
T3SS, and we propose that a signaling pathway exists that
links the two. Interestingly, the Parsot laboratory recently
showed that ABM provided by IcsA is required for reactivation
of the T3SS during intercellular spread, further emphasizing the
idea that there is crosstalk between these virulence strategies
(Campbell-Valois et al., 2014).
How does DOC activate the T3SS? IpaD resides at the
needle tip, and several studies demonstrated that DOC can442 Cell Host & Microbe 15, 435–445, April 9, 2014 ª2014 Elsevier Inbind directly to IpaD, resulting in a conformational change
within the protein (Dickenson et al., 2011; Espina et al., 2006;
Sani et al., 2007; Stensrud et al., 2008). Impressively, when
one residue within the DOC binding pocket of IpaDwasmutated,
S. flexneri retained the ability to invade epithelial cells, but
invasion was no longer enhanced by DOC treatment (Barta
et al., 2012). This shows that DOC signaling occurs through
IpaD, and our results suggest that a DipaDmutant mimics signal
transduction events induced by DOC.
In addition to IcsA-dependent adhesion, we observed IcsA-
independent binding of wild-type S. flexneri to host cells upon
DOC treatment. IcsA-independent binding also required the
T3SS for activation, but was independent of OspE1/OspE2 and
MxiE in our system. It is interesting that IcsA-dependent adhe-
sion enhances invasion of S. flexneri, but IcsA-independent
binding does not. We can only speculate that this is caused by
inherent differences between the adhesion methods. In Yersinia
pestis, adhesion through invasin or YadA can improve delivery of
the T3SS effector YopE (Rosqvist et al., 1990), showing a direct
relationship between adhesion to host cells and effector delivery.
However, it is also possible that there is coordination between
IcsA and the T3SS. Surprisingly, Tran Van Nhieu lab showed
that secretion of the translocon protein IpaC occurs at one
pole of the bacterium (Jaumouille´ et al., 2008). Moreover, their
study showed that cytosolic IpaC accumulates at the same
pole as IcsA prior to secretion. Together, these data suggest
that the bacterium is primed to deliver effector proteins to the
pole adhering to host cells, thereby optimizing effector delivery
and invasion.
What is the host cell receptor for IcsA? We are unable to
conclude this from our current data, but we predict that the re-
ceptor targeted by IcsA is widely distributed. Shigella species
are human-restricted pathogens, but S. flexneri mutants hyper-
adhered to mouse and human cells, suggesting that IcsA does
not contribute to host restriction. Likewise, IcsA-dependent
adhesion did not show specificity for any cell type, since the
DipaD mutant hyperadheres to epithelial cells, macrophages,
and PMNs. Three host cell proteins have been shown to directly
bind IcsA, including N-WASP, ATG5, and vinculin (Egile et al.,
1999; Ogawa et al., 2005; Suzuki et al., 1996, 1998). These pro-
teins all have a cytosolic localization, suggesting that they are
unlikely to be the host cell receptor targeted by IcsA. A corollary
of these data is that IcsA probably targets different host proteins
for ABM and adhesion.
IcsA is required for virulence in animals and humans, leading
us to wonder whether IcsA-dependent adhesion contributes to
pathogenesis (Bernardini et al., 1989; Kotloff et al., 2002; Makino
et al., 1986; Sansonetti et al., 1991). Since we propose that IcsA
plays dual roles in shigellosis, we screened for a mutant that
formed plaques, similar to the wild-type, but was attenuated
for adhesion. We successfully identified this mutant, which we
call IcsAadhesion. The mutant has important implications for
understanding how IcsA plays dual roles because it suggests
that IcsA contains distinct regions that contribute to each
function. We found that the IcsAadhesionmutant was attenuated
in vivo, confirming a role for IcsA-dependent adhesion in
Shigella pathogenesis.
In spite of the significance of dysentery, there is no available
Shigella vaccine, though many strategies have been proposedc.
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Most live-attenuated vaccine approaches combine deletions of
icsA with one or more loci. The rationale for this strategy is that
a live strain would allow intestinal invasion and elicit a mucosal
immune response, but the icsA mutation would restrict its repli-
cation because of an inability to spread. A live vaccine carrying
an icsA deletion was recently tested in an endemic population
but, unfortunately, was not immunogenic (Rahman et al.,
2011). Since the vaccine strain was not shed from the vaccinated
individuals, the authors of the study concluded that it could not
effectively colonize vaccines. Our results, showing that IcsA is
an adhesin, might explain this lack of colonization. We suggest
that an alternate approach that elicits antibodies against IcsA
has the potential to inhibit initial stages of infection and prevent
disease.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
The bacterial strains used in the study are listed in Table S1, along with the
primers and strategies used to generate knockouts and complementation
plasmids (Table S2). For all infections, bacteria were grown overnight in tryptic
soy broth in the presence or absence of 2.5 mM sodium deoxycholate (Fluka),
and antibiotics chloramphenicol (6 mg/ml), kanamycin (40 mg/ml), or carbenicil-
lin (100 mg/ml) were added when appropriate. To induce expression of IcsA
from pBAD, bacterial cultures were grown overnight in the presence of 0.2%
L-arabinose (Sigma) in S. flexneri or 0.02% arabinose in E. coli BL21.
Host Cell Isolation and Maintenance
HeLa cells and Caco-2 cells were routinely grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with L-glutamine, 10% fetal calf
serum, and penicillin/streptomycin. The day prior to infection (HeLa) or
2 days prior to infection (Caco-2), cells were seeded at 1 3 105/well in antibi-
otic-free media. BMDMs were isolated and cultured as described previously
(Schaible and Kaufmann, 2002) and were seeded at 3 3 105/well. Human
neutrophils were isolated following the histopaque/percoll protocol detailed
in (Ermert et al., 2009). All donors gave consent to blood drawing in accor-
dance with the Declaration of Helsinki, and samples were collected with
approval from the ethical committee. PMNs were seeded on glass coverslips
at 5 3 105 cells/well in RPMI with 10 mM HEPES 30 min prior to infection.
Adherence and Invasion Assays
To quantify bacterial adherence to BMDMs or epithelial cells, overnight cul-
tures of S. flexneri or E. coli strains were washed twice with PBS, then added
at a multiplicity of infection (moi) of 20:1 or 30:1 (bacteria to host cell), respec-
tively. Plates were spun for 5 min at 7003 g then placed at 37C. After 15 min,
host cells were washed three times with warm media then lysed with 0.1%
Triton X-100 in PBS, and bacteria were enumerated by serial dilution plating.
For invasion assays, HeLa cells were infected similarly, but at 30 min postin-
fection, 50 mg/ml gentamicin was added to the media. At 1.5 hr postinfection,
HeLa cells were washed and lysed with 0.1% Triton in PBS, and bacteria were
enumerated. Adhesion rate is calculated as the output/input3100. Adherence
to PMNs and HeLa was examined microscopically using cells attached to
glass coverslips. PMNswere infected with anmoi of 50:1 (colony-forming units
(cfu)/PMN) and HeLa at an moi of 100:1 then washed and fixed with 2% para-
formaldehyde at 15 min postinfection. For microscopy, infections were per-
formed with S. flexneri strains expressing DsRed, actin was stained using
Alexa Fluor 488 phalloidin (Invitrogen), and nuclei were stained using DAPI.
Quantification by microscopy was performed using ImageJ software.
Flow Cytometry Analysis to Quantify Surface Levels of IcsA
To quantify surface levels of IcsA, 1 3 109 bacteria from overnight cultures
were washed twice in PBS and fixed with 2% paraformaldehyde for 30 min.
Bacteria (1 3 107) were then blocked with 1% BSA in PBS for 30 min,
incubated with primary antibody (1:100) for 1 hr (rabbit anti-icsA, a gift fromCellthe Sansonetti lab), and washed with PBS, then anti-rabbit PE (eBioscience)
was added at 1:200 for 1 hr. Bacteria were then washed and analyzed by
flow cytometry (MACSQuant Analyzer). Fluorescence-activated cell sorting
(FACS) data were analyzed using FlowJo software v.10, and any aggregated
bacteria were removed from analysis by gating.
Scanning Electron Microscopy
For scanning electron microscopy, PMNs and BMDMs were infected with an
moi of 100:1 (PMNs) or 20:1 (BMDMs) cfu/host cell. Plates were spun as
above, then washed and fixed with 2.5% glutaraldehyde at 3 min postinfec-
tion. Samples were postfixed in 0.5% osmium-tetroxide, tannic acid, and
osmium-tetroxide again. Coverslips were then dehydrated in a graded ethanol
series, dried in carbon dioxide at critical point, and vacuum coated with 3 nm
carbon-platinum. Imaging was performed using in-lens signals in a LEO 1550
(Zeiss) scanning electron microscope at 10 kV acceleration voltage.
Trichloroacetic Acid Precipitations
To determine proteins secreted by S. flexneri strains, trichloroacetic acid (TCA)
precipitations were performed as in Dohlich et al. (2014).
Immunofluorescence Staining of IcsA
To determine the distribution of IcsA on the surface of S. flexneri by immu-
nofluorescence, bacteria were centrifuged onto glass coverslips and then
fixed with 2% PFA for 30 min. Coverslips were washed and blocked with
1% BSA in PBS for 30 min. Antibody against IcsA was added at 1:100 in 1%
BSA/PBS for 1 hr. Coverslips were washed, then anti-rabbit Alexa Fluor 488
(Molecular Probes) was added at 1:200 for 1 hr. To determine the outline
of the bacterium, images were taken using differential interference contrast
microscopy (DIC).
Limited Proteolysis Assay
Overnight cultures of S. flexneri were pelleted, washed twice with PBS, and
resuspended at 1 3 109 cfu/ml. A 0.5 ml aliquot was placed at 37C, and
neutrophil elastase (25–34 nM, Elastin Products) or proteinase K (2 mg/ml,
Thermo Scientific) was added to the intact bacteria, as indicated in the figure
legends. At the indicated time points, a 50 ul aliquot was taken, resuspended
in an equal volume of 23 sample buffer, and immediately boiled. A total of 20 ml
from each sample was run on any kD gels (Bio-Rad), and IcsA degradation was
assessed by western blot using a rabbit antibody against HA (Sigma).
Sereny Test
Experiments involving mice were performed with the approval of Landesamt
fu¨r Gesundheit und Soziales. Mice were infected as described previously
(Moss et al., 2000) and monitored daily for keratoconjunctivitis. Eyes were
blindly scored by an independent researcher on a scale of 0–2, and signifi-
cance was calculated using a Mann-Whitney test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
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